CVS HEALTH CORPORATION |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 57.5 USD | -0.32% |
|
+1.98% | -27.06% |
| 16/05 | CVS Health Retail Division Launches Snacks Brand Well Market | MT |
| 14/05 | Transcript : CVS Health Corporation Presents at Bank of America Health Care Conference 2024, May-14-2024 07:20 AM |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Exceptional extension!
Take advantage of the offer
* See conditions on site
| Sales 2024 * | 369B 30,720B | Sales 2025 * | 388B 32,308B | Capitalization | 72.41B 6,028B |
|---|---|---|---|---|---|
| Net income 2024 * | 7.66B 638B | Net income 2025 * | 8.92B 743B | EV / Sales 2024 * | 0.33 x |
| Net Debt 2024 * | 48.83B 4,065B | Net Debt 2025 * | 45.01B 3,747B | EV / Sales 2025 * | 0.3 x |
| P/E ratio 2024 * |
9.94
x | P/E ratio 2025 * |
8.49
x | Employees | 2,59,500 |
| Yield 2024 * |
4.61% | Yield 2025 * |
4.57% | Free-Float | 70.67% |
More Fundamentals
* Assessed data
More news
Latest transcript on CVS Health Corporation
More recommendations
More press releases
More news
| 1 day | -0.31% | ||
| 1 week | +1.98% | ||
| Current month | -14.95% | ||
| 1 month | -17.29% | ||
| 3 months | -24.53% | ||
| 6 months | -15.63% | ||
| Current year | -27.06% |
1 week
55.20
57.87
1 month
53.7070.21
Current year
53.7083.25
1 year
53.7083.25
3 years
53.70111.25
5 years
52.04111.25
10 years
51.72113.65
| Managers | Title | Age | Since |
|---|---|---|---|
Karen Lynch
CEO | Chief Executive Officer | 61 | 28/18/28 |
Thomas Cowhey
DFI | Director of Finance/CFO | 51 | 01/22/01 |
Tilak Mandadi
CTO | Chief Tech/Sci/R&D Officer | - | 25/22/25 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Anne Finucane
BRD | Director/Board Member | 71 | 20/11/20 |
Fernando Aguirre
BRD | Director/Board Member | 66 | 28/18/28 |
Mary Schapiro
BRD | Director/Board Member | 68 | 10/17/10 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 3.92% | 17 M€ | +8.10% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 20/24/20 | 57.6 | -0.14% | 5 803 840 |
| 17/24/17 | 57.68 | +0.28% | 9,607,690 |
| 16/24/16 | 57.52 | +2.24% | 13,974,759 |
| 15/24/15 | 56.26 | +0.46% | 16,430,970 |
| 14/24/14 | 56 | -0.83% | 15,410,680 |
Delayed Quote Nyse, May 20, 2024 at 11:17 pm IST
More quotes
CVS Health Corporation is one of the leading American suppliers of health products and services. Net sales (including intragroup) break down by activity as follows:
- medical insurance plan management services (45.6%; Pharmacy Benefit Management): administrative management (reimbursement management, patient claim processing, etc.), drug distribution, decision-making information, sales of medical information management services, etc.;
- retail distribution (28.5%): sale of prescription pharmaceutical products, OTC products, beauty and cosmetics products. At the end of 2023, products are marketed primarily via a network of more than 9,000 outlets and via the Internet. In addition, the group offers healthcare services through more than 1,000 clinics (MinuteClinic®);
- medical benefits management (25.8%);
- other (0.1%).
Calendar
31/07/2024
- Q2 2024 Earnings Release (Projected)
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
57.68
USD
Average target price
71.37
USD
Spread / Average Target
+23.74%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -27.06% | 72.41B | |
| +19.18% | 84.56B | |
| +2.04% | 27.73B | |
| -8.53% | 17.75B | |
| -1.14% | 17.11B | |
| +5.35% | 16.03B | |
| +70.31% | 13.07B | |
| +6.66% | 12.91B | |
| +72.07% | 12.55B | |
| +34.26% | 12.26B |
- Stock Market
- Equities
- CVS Stock